Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

Japan to roll out COVID-19 booster targeting XBB subvariant in the fall

Mon, 2023-06-19 10:01 — mike kraft

Japan to roll out COVID-19 booster targeting XBB subvariant in the fall A vaccine subcommittee under the health ministry is aiming to prepare for another spike in infections possibly arriving in the winter. Tomoko Otake The Japan Times

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Japan to roll out COVID-19 booster targeting XBB subvariant in the fall
Log in or register to post comments

COVID vaccine records in Texas, New Hampshire, Montana could be lost because of opt-in -laws

Fri, 2023-06-16 10:59 — mike kraft

Your COVID vaccine records could be destroyed in 5 years because of Texas law In five years, Texas will have to destroy 10.4 million vaccine records because of an unusual state law. Yahoo News

The impending record destruction is a rare situation in the U.S., because almost every state or municipality that operates a vaccine registry has an “opt out” system.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID vaccine records in Texas, New Hampshire, Montana could be lost because of opt-in -laws
Log in or register to post comments

COVID-19 vaccine safety for adults confirmed in 2 new studies

Fri, 2023-06-16 10:09 — mike kraft

COVID-19 vaccines shown safe in 2 new studies Data show COVID-19 vaccines are safe in older adults and when administered with non-COVID vaccines. CIDRAP

Two new studies show COVID-19 vaccines are safe in older adults and when administered simultaneously with non-COVID vaccines. Both studies are published in Vaccine.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID-19 vaccine safety for adults confirmed in 2 new studies
Log in or register to post comments

FDA advisors endorse using only updated Covid vaccines

Thu, 2023-06-15 17:31 — mike kraft

FDA advisers endorse updating COVID vaccines to target latest omicron strain The COVID-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic. But that strain was long ago supplanted by mutated versions as the virus rapidly evolves. Scientific advisers for the Food and Drug Administration on Thursday said the next round of shots should only include protection against the newest omicron variants that are now dominant worldwide.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA advisors endorse using only updated Covid vaccines
Log in or register to post comments

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

Mon, 2023-06-12 18:05 — mike kraft

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say
Log in or register to post comments

U.S. FDA panel unanimously votes in favor of RSV antibody treatment for infants

Thu, 2023-06-08 19:14 — mike kraft

FDA panel unanimously votes in favor of RSV antibody treatment for infants The Food and Drug Administration’s (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving a respiratory syncytial virus (RSV) treatment for infants, bring… jchoi The Hill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA panel unanimously votes in favor of RSV antibody treatment for infants
Log in or register to post comments

Analysis of how pandemic changed attitudes toward mandating childhood vaccinations

Thu, 2023-06-08 11:05 — mike kraft

Pandemic changed attitudes toward mandating childhood vaccinations CIDRAP

A new analysis of 21 polls conducted before and after the COVID-19 pandemic shows parents are changing how they think about school vaccination mandates, but not about vaccine safety.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis of how pandemic changed attitudes toward mandating childhood vaccinations
Log in or register to post comments

EU approves its first vaccine for common respiratory virus RSV

Wed, 2023-06-07 12:06 — mike kraft

EU approves its first vaccine for common respiratory virus RSV European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually. Natalie Grover,Eva Mathews Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about EU approves its first vaccine for common respiratory virus RSV
Log in or register to post comments

Large study shows safety of COVID mRNA vaccines in young children

Wed, 2023-06-07 10:15 — mike kraft

Large study shows safety of COVID mRNA vaccines in young children CIDRAP

Messenger RNA vaccines for COVID-19 pose little risk to young children, with no myocarditis (inflammation of heart muscle) or pericarditis (inflammation around the heart) observed in vaccine recipients age 0 to 4. The reassuring findings were published today in Pediatrics.

...

Country / Region Tags:

General Topic Tags: